Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study

Table 5 Antimicrobial sensitivity in patients who suffered from single vs repeated episodes of infection n (%)

Antimicrobial		All episodes of infection (n = 57)	Single episode of infection (n = 21)	Repeated pisodes of infection (n = 36)	P value
Levofloxacin	S	11 (52.4)	2 (22.2)	9 (75.0)	0.030
	R	10 (47.6)	7 (77.8)	3 (25.0)
Ciprofloxacin	S	5 (38.5)	0 (0.0)	5 (45.5)	0.487
	R	8 (61.5)	2 (100.0)	6 (54.5)
Co-trimoxazole	S	1 (7.1)	0 (0.0)	1 (10.0)	1.000
	R	13 (92.9)	4 (100.0)	9 (90.0)
Penicillin	S	1 (11.1)	1 (14.3)	0 (0.0)	1.000
	R	8 (88.9)	6 (85.7)	2 (100.0)
Doxycycline	S	14 (77.8)	5 (100.0)	9 (69.2)	0.278
	R	4 (22.2)	0 (0.0)	4 (30.8)
Vancomycin	S	8 (88.9)	4 (100.0)	4 (80.0)	1.000
	R	1 (11.1)	0 (0.0)	1 (20.0)
Piperacillin-tazobactam	S	8 (72.7)	3 (75.0)	5 (71.4)	1.000
	R	3 (27.3)	1 (25.0)	2 (28.6)
Aminoglycosides	S	9 (75.0)	1 (50.0)	8 (80.0)	0.455
	R	3 (25.0)	1 (50.0)	2 (20.0)
Imipenem	S	20 (69.0)	8 (88.9)	12 (60.0)	0.201
	R	9 (31.0)	1 (11.1)	8 (40.0)
Ceftrioxone	S	7 (38.9)	1 (16.7)	6 (50.0)	0.316
	R	11 (61.1)	5 (83.3)	6 (50.0)
Cefotaxime	R	8 (100.0)	7 (100.0)	1 (100.0)	-
Aztreonam	R	6 (100.0)	1 (100.0)	5 (100.0)	-

S: Sensitive; R: Resistant.